Stocks
GlaxoSmithKline (GSK) Book value US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Book value, £ | -34 641 413 200 | -10 766 000 000 | -10 494 153 600 | -8 826 000 000 | -7 376 013 000 | -9 986 516 000 | |||
| Changes by years, y/y, % | -2% | -69% | -3% | -16% | -16% | -26.9% | |||
GlaxoSmithKline. Book value, £
GlaxoSmithKline. Book value, changes, %
GlaxoSmithKline (GSK) Book value US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Book value, £ | -10 546 522 000 | -7 376 013 000 | -7 376 013 000 | -9 986 516 000 | -6 498 538 000 | -9 986 516 000 | ||
| Changes by years, y/y, % | +37% | -16% | -16% | -14% | -35% | |||
| Changes by quarters, q/q, % | +5% | -30% | 0% | +35% | -35% | |||
